What is a stock summary page? Click here for an overview.
Business Description
Zomedica Corp
NAICS : 423450
SIC : 3912
ISIN : CA98979F1071
Share Class Description:
ZOMDF: Ordinary SharesDescription
Zomedica Corp is a veterinary health company creating products for companion animals (canine, feline and equine) by focusing on the unmet needs of clinical veterinarians. The company's product portfolio includes diagnostics and therapeutics that emphasize patient health and practice health. The company is focused on the final development and commercialization of its TRUFORMA platform, which detects thyroid disorders in dogs & cats and adrenal disorders in dogs. Its operations are comprised of two reportable segments namely Diagnostic and Therapeutic Devices. It earns the majority of revenue from the therapeutics segment.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 39.34 | |||||
| Equity-to-Asset | 0.94 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | -0.05 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 0.8 | |||||
| Beneish M-Score | -2.41 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 91.3 | |||||
| 3-Year EBITDA Growth Rate | -26 | |||||
| 3-Year EPS without NRI Growth Rate | 12.9 | |||||
| 3-Year FCF Growth Rate | -27.4 | |||||
| 3-Year Book Growth Rate | -10.2 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 28.98 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 55.83 | |||||
| 9-Day RSI | 46.55 | |||||
| 14-Day RSI | 42.89 | |||||
| 3-1 Month Momentum % | -47.54 | |||||
| 6-1 Month Momentum % | -45.7 | |||||
| 12-1 Month Momentum % | -50.08 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 8.76 | |||||
| Quick Ratio | 8.22 | |||||
| Cash Ratio | 7.65 | |||||
| Days Inventory | 233.11 | |||||
| Days Sales Outstanding | 22.5 | |||||
| Days Payable | 136.88 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -0.62 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 69.95 | |||||
| Operating Margin % | -128.38 | |||||
| Net Margin % | -172.19 | |||||
| FCF Margin % | -111.5 | |||||
| ROE % | -21.77 | |||||
| ROA % | -20.64 | |||||
| ROIC % | -24.2 | |||||
| 3-Year ROIIC % | -31.03 | |||||
| ROC (Joel Greenblatt) % | -171.33 | |||||
| ROCE % | -21.69 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 1.89 | |||||
| PB Ratio | 0.25 | |||||
| Price-to-Tangible-Book | 0.5 | |||||
| EV-to-EBIT | 0.46 | |||||
| EV-to-EBITDA | 0.55 | |||||
| EV-to-Revenue | -0.8 | |||||
| EV-to-Forward-Revenue | 0.96 | |||||
| EV-to-FCF | 0.72 | |||||
| Price-to-GF-Value | 0.19 | |||||
| Price-to-Net-Current-Asset-Value | 0.71 | |||||
| Price-to-Net-Cash | 0.83 | |||||
| Earnings Yield (Greenblatt) % | 217.39 | |||||
| FCF Yield % | -62.09 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:ZOMDF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Zomedica Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 27.285 | ||
| EPS (TTM) ($) | -0.053 | ||
| Beta | 2.02 | ||
| 3-Year Sharpe Ratio | -0.67 | ||
| 3-Year Sortino Ratio | -0.93 | ||
| Volatility % | 55.56 | ||
| 14-Day RSI | 42.89 | ||
| 14-Day ATR ($) | 0.008595 | ||
| 20-Day SMA ($) | 0.051641 | ||
| 12-1 Month Momentum % | -50.08 | ||
| 52-Week Range ($) | 0.0151 - 0.1952 | ||
| Shares Outstanding (Mil) | 979.95 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Zomedica Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Zomedica Corp Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Zomedica Corp Frequently Asked Questions
What is Zomedica Corp(ZOMDF)'s stock price today?
The current price of ZOMDF is $0.05. The 52 week high of ZOMDF is $0.20 and 52 week low is $0.02.
When is next earnings date of Zomedica Corp(ZOMDF)?
The next earnings date of Zomedica Corp(ZOMDF) is 2025-05-09 Est..
Does Zomedica Corp(ZOMDF) pay dividends? If so, how much?
Zomedica Corp(ZOMDF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers